US 12187799
Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 12187799 (Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor) held by The Board of Regents of the University of Texas System expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61P, A61P35/00